Research is being conducted on the effectiveness of combination therapy versus monotherapy in treating type 2 diabetes. Studies are comparing clinical outcomes of patients on single-drug regimens to those on multiple-drug regimens, with some focusing on the role of metformin as a foundational treatment. The use of early combination therapy appears to be gaining consideration, with various treatment approaches and medication combinations being explored.